Four-year clinical results of transcatheter self-expanding Medtronic CoreValve implantation in high-risk patients with severe aortic stenosis

Conclusion: our study demonstrated favourable long-term (4 years) outcomes after successful TAVI using the third-generation Medtronic CoreValve device.

Source: Age and Ageing - April 26, 2016 Category: Geriatrics Authors: Thomopoulou, S., Vavuranakis, M., Karyofyllis, P., Kariori, M., Karavolias, G., Balanika, M., Smyrli, A., Stefopoulos, C., Sbarouni, E., Moldovan, C., Khoury, M., Stefanadis, C., Voudris, V. Tags: Short Reports Source Type: research